126 related articles for article (PubMed ID: 3410375)
1. [Effects of E-3123, a new protease inhibitor, on several protease activities and on experimental acute pancreatitis].
Miyamoto K; Hishinuma I; Nagakawa J; Nagaoka N; Yamanaka T; Wakabayashi T
Nihon Yakurigaku Zasshi; 1988 May; 91(5):285-93. PubMed ID: 3410375
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
Iwaki M; Ino Y; Motoyoshi A; Ozeki M; Sato T; Kurumi M; Aoyama T
Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological studies of FUT-175, nafamstat mesilate. II. Effects on experimental acute pancreatitis].
Iwaki M; Ozeki M; Sato T; Suzuki K; Motoyoshi A; Suzuki S; Fujita M; Aoyama T
Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):363-72. PubMed ID: 6210233
[TBL] [Abstract][Full Text] [Related]
4. E-3123, a new synthetic protease inhibitor, protects against deoxycholic acid-induced acute pancreatitis in dogs.
Iwatsuki K; Horiuchi A; Yonekura H; Ren LM; Chiba S
Arch Int Pharmacodyn Ther; 1990; 308():168-77. PubMed ID: 1711836
[TBL] [Abstract][Full Text] [Related]
5. [Effect of continuous arterial infusion of protease inhibitor on experimental acute pancreatitis induced by closed duodenal loop obstruction].
Kakugawa Y; Takeda K; Sunamura M; Kawaguchi S; Kobari M; Matsuno S
Nihon Shokakibyo Gakkai Zasshi; 1990 Jun; 87(6):1444-50. PubMed ID: 2214268
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis.
Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A
Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic effects of human urinary trypsin inhibitor on acute experimental pancreatitis].
Ohnishi H; Kosuzume H; Ashida Y; Kato K; Suzuki Y; Honjo I
Nihon Yakurigaku Zasshi; 1983 Mar; 81(3):235-44. PubMed ID: 6345304
[TBL] [Abstract][Full Text] [Related]
8. Rat experimental model of continuous regional arterial infusion of protease inhibitor and its effects on severe acute pancreatitis.
Mikami Y; Takeda K; Matsuda K; Qiu-Feng H; Fukuyama S; Egawa S; Sunamura M; Matsuno S
Pancreas; 2005 Apr; 30(3):248-53. PubMed ID: 15782103
[TBL] [Abstract][Full Text] [Related]
9. Synthetic antiproteases in acute pancreatitis: an experimental study.
Dobosz M; Sledziński Z; Babicki A; Juszkiewicz P; Basiński A; Wajda Z
Mt Sinai J Med; 1992 Jan; 59(1):43-6. PubMed ID: 1734237
[TBL] [Abstract][Full Text] [Related]
10. Prevention of experimental acute pancreatitis by intraduodenal trypsin inhibitor in rat.
Ono H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Kiriyama S; Sobajima H
Dig Dis Sci; 1990 Jun; 35(6):787-92. PubMed ID: 2344814
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats.
Naruse S; Wang Y; Kitagawa M; Ishiguro H; Seki Y; Ozaki T; Hayakawa T
Pancreas; 2000 Oct; 21(3):290-5. PubMed ID: 11039474
[TBL] [Abstract][Full Text] [Related]
12. The effects of nafamostat mesilate (FUT-175) on caerulein-induced acute pancreatitis in the rat.
Wisner JR; Ozawa S; Renner IG
Int J Pancreatol; 1989 May; 4(4):383-90. PubMed ID: 2732529
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic regimens in acute experimental pancreatitis in rats: effects of a protease inhibitor, a beta-agonist, and antibiotics.
Araida T; Frey CF; Ruebner B; Carlson J; King J
Pancreas; 1995 Aug; 11(2):132-40. PubMed ID: 7479669
[TBL] [Abstract][Full Text] [Related]
15. Continuous regional application of protease inhibitor in the treatment of acute pancreatitis. An experimental study using closed duodenal obstruction model in dogs.
Yamauchi J; Takeda K; Shibuya K; Sunamura M; Matsuno S
Pancreatology; 2001; 1(6):662-7. PubMed ID: 12120251
[TBL] [Abstract][Full Text] [Related]
16. Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat.
Wisner JR; Renner IG; Grendell JH; Niederau C; Ferrell LD
Pancreas; 1987; 2(2):181-6. PubMed ID: 2442741
[TBL] [Abstract][Full Text] [Related]
17. Monitoring serum tryptic activity and effect of trypsin inhibitor on rat acute pancreatitis.
Sobajima H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Ishiguro H; Tanikawa M; Nakae Y
Digestion; 1994; 55(2):90-6. PubMed ID: 7514553
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological studies of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate. Effects on experimental pancreatitis.
Murakami H; Togawa M; Takahashi S; Kasahara N; Yamamoto J; Matsuura N; Koshiyama Y; Ino Y; Oda M
Arzneimittelforschung; 1990 Dec; 40(12):1352-8. PubMed ID: 2095132
[TBL] [Abstract][Full Text] [Related]
19. Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis.
Lee JK; Ryu JK; Park JK; Lee SH; Yoon WJ; Kim YT; Jung HC; Yoon YB
Pancreas; 2008 Apr; 36(3):255-60. PubMed ID: 18362838
[TBL] [Abstract][Full Text] [Related]
20. Nafamostat mesilate on the course of acute pancreatitis. Protective effect on peritoneal permeability and relation with supervening pulmonary distress.
Marotta F; Fesce E; Rezakovic I; Chui DH; Suzuki K; Idéo G
Int J Pancreatol; 1994 Aug; 16(1):51-9. PubMed ID: 7528762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
